136 related articles for article (PubMed ID: 21877998)
1. Failure of oral DHEA treatment to increase local salivary androgen outputs of female patients with Sjögren's syndrome.
Porola P; Straub RH; Virkki LM; Konttinen YT; Nordström DC
Scand J Rheumatol; 2011; 40(5):387-90. PubMed ID: 21877998
[TBL] [Abstract][Full Text] [Related]
2. Androgen deficiency and defective intracrine processing of dehydroepiandrosterone in salivary glands in Sjögren's syndrome.
Porola P; Virkki L; Przybyla BD; Laine M; Patterson TA; Pihakari A; Konttinen YT
J Rheumatol; 2008 Nov; 35(11):2229-35. PubMed ID: 18843777
[TBL] [Abstract][Full Text] [Related]
3. Low salivary dehydroepiandrosterone and androgen-regulated cysteine-rich secretory protein 3 levels in Sjögren's syndrome.
Laine M; Porola P; Udby L; Kjeldsen L; Cowland JB; Borregaard N; Hietanen J; Ståhle M; Pihakari A; Konttinen YT
Arthritis Rheum; 2007 Aug; 56(8):2575-84. PubMed ID: 17665393
[TBL] [Abstract][Full Text] [Related]
4. Low serum levels of sex steroids are associated with disease characteristics in primary Sjogren's syndrome; supplementation with dehydroepiandrosterone restores the concentrations.
Forsblad-d'Elia H; Carlsten H; Labrie F; Konttinen YT; Ohlsson C
J Clin Endocrinol Metab; 2009 Jun; 94(6):2044-51. PubMed ID: 19318446
[TBL] [Abstract][Full Text] [Related]
5. Dehydroepiandrosterone (DHEA) substitution treatment for severe fatigue in DHEA-deficient patients with primary Sjögren's syndrome.
Virkki LM; Porola P; Forsblad-d'Elia H; Valtysdottir S; Solovieva SA; Konttinen YT
Arthritis Care Res (Hoboken); 2010 Jan; 62(1):118-24. PubMed ID: 20191499
[TBL] [Abstract][Full Text] [Related]
6. Physiological changes in dehydroepiandrosterone are not reflected by serum levels of active androgens and estrogens but of their metabolites: intracrinology.
Labrie F; Bélanger A; Cusan L; Candas B
J Clin Endocrinol Metab; 1997 Aug; 82(8):2403-9. PubMed ID: 9253308
[TBL] [Abstract][Full Text] [Related]
7. Sjögren's syndome and extragonadal sex steroid formation: a clue to a better disease control?
Konttinen YT; Stegajev V; Al-Samadi A; Porola P; Hietanen J; Ainola M
J Steroid Biochem Mol Biol; 2015 Jan; 145():237-44. PubMed ID: 25158020
[TBL] [Abstract][Full Text] [Related]
8. Salivary resistin reflects local inflammation in Sjögren's syndrome.
Boström EA; d'Elia HF; Dahlgren U; Simark-Mattsson C; Hasséus B; Carlsten H; Tarkowski A; Bokarewa M
J Rheumatol; 2008 Oct; 35(10):2005-11. PubMed ID: 18709689
[TBL] [Abstract][Full Text] [Related]
9. Are women with Sjögren's syndrome androgen-deficient?
Sullivan DA; Bélanger A; Cermak JM; Bérubé R; Papas AS; Sullivan RM; Yamagami H; Dana MR; Labrie F
J Rheumatol; 2003 Nov; 30(11):2413-9. PubMed ID: 14677186
[TBL] [Abstract][Full Text] [Related]
10. Pilot clinical trial of dehydroepiandrosterone (DHEA) versus placebo for Sjögren's syndrome.
Pillemer SR; Brennan MT; Sankar V; Leakan RA; Smith JA; Grisius M; Ligier S; Radfar L; Kok MR; Kingman A; Fox PC
Arthritis Rheum; 2004 Aug; 51(4):601-4. PubMed ID: 15334433
[TBL] [Abstract][Full Text] [Related]
11. Effect of dehydroepiandrosterone administration on fatigue, well-being, and functioning in women with primary Sjögren syndrome: a randomised controlled trial.
Hartkamp A; Geenen R; Godaert GL; Bootsma H; Kruize AA; Bijlsma JW; Derksen RH
Ann Rheum Dis; 2008 Jan; 67(1):91-7. PubMed ID: 17545193
[TBL] [Abstract][Full Text] [Related]
12. Androgens and integrins in salivary glands in Sjogren's syndrome.
Porola P; Laine M; Virtanen I; Pöllänen R; Przybyla BD; Konttinen YT
J Rheumatol; 2010 Jun; 37(6):1181-7. PubMed ID: 20436081
[TBL] [Abstract][Full Text] [Related]
13. Low serum dehydroepiandrosterone sulfate in women with primary Sjögren's syndrome as an isolated sign of impaired HPA axis function.
Valtysdóttir ST; Wide L; Hällgren R
J Rheumatol; 2001 Jun; 28(6):1259-65. PubMed ID: 11409117
[TBL] [Abstract][Full Text] [Related]
14. Healthy human salivary glands contain a DHEA-sulphate processing intracrine machinery, which is deranged in primary Sjögren's syndrome.
Spaan M; Porola P; Laine M; Rozman B; Azuma M; Konttinen YT
J Cell Mol Med; 2009 Jul; 13(7):1261-70. PubMed ID: 19298523
[TBL] [Abstract][Full Text] [Related]
15. Sex steroid hormones in primary Sjögren's syndrome.
Brennan MT; Sankar V; Leakan RA; Grisius MM; Collins MT; Fox PC; Baum BJ; Pillemer SR
J Rheumatol; 2003 Jun; 30(6):1267-71. PubMed ID: 12784401
[TBL] [Abstract][Full Text] [Related]
16. Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging.
Labrie F; Bélanger A; Cusan L; Gomez JL; Candas B
J Clin Endocrinol Metab; 1997 Aug; 82(8):2396-402. PubMed ID: 9253307
[TBL] [Abstract][Full Text] [Related]
17. Salivary and serum interleukin 6 in primary Sjögren's syndrome.
Grisius MM; Bermudez DK; Fox PC
J Rheumatol; 1997 Jun; 24(6):1089-91. PubMed ID: 9195514
[TBL] [Abstract][Full Text] [Related]
18. Dendrobium candidum extract increases the expression of aquaporin-5 in labial glands from patients with Sjögren's syndrome.
Xiao L; Ng TB; Feng YB; Yao T; Wong JH; Yao RM; Li L; Mo FZ; Xiao Y; Shaw PC; Li ZM; Sze SC; Zhang KY
Phytomedicine; 2011 Jan; 18(2-3):194-8. PubMed ID: 20655712
[TBL] [Abstract][Full Text] [Related]
19. Clinical and histologic evidence of salivary gland restoration supports the efficacy of rituximab treatment in Sjögren's syndrome.
Pijpe J; Meijer JM; Bootsma H; van der Wal JE; Spijkervet FK; Kallenberg CG; Vissink A; Ihrler S
Arthritis Rheum; 2009 Nov; 60(11):3251-6. PubMed ID: 19877054
[TBL] [Abstract][Full Text] [Related]
20. Increased circulating levels and salivary gland expression of interleukin-18 in patients with Sjögren's syndrome: relationship with autoantibody production and lymphoid organization of the periductal inflammatory infiltrate.
Bombardieri M; Barone F; Pittoni V; Alessandri C; Conigliaro P; Blades MC; Priori R; McInnes IB; Valesini G; Pitzalis C
Arthritis Res Ther; 2004; 6(5):R447-56. PubMed ID: 15380044
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]